The Annals the journal of Pharmacy Technology
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 30, No. 12, pp. 1396-1398.
© 1996 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chou, J.
Right arrow Articles by Czobor, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chou, J.
Right arrow Articles by Czobor, P

Research Articles

Neuroleptics in acute mania: a pharmacoepidemiologic study

JC Chou, JM Zito, J Vitrai, TJ Craig, BH Allingham, and P Czobor

OBJECTIVE: To provide an epidemiologic descriptive analysis of the acute drug treatment of inpatients with bipolar mania in state psychiatric facilities in 1990. METHODS: We surveyed the first 3 weeks of drug treatment of all inpatients with bipolar mania who were admitted to 22 New York State adult psychiatric facilities during a 6-month period (n = 528). RESULTS: Almost all patients with mania were treated with neuroleptics. The mean +/- SD neuroleptic dosage was 684 +/- 543 mg/d chlorpromazine equivalents. Sixty-one percent of the patients received lithium and 12% received carbamazepine or valproate. Neuroleptic dosage was related to age, with older patients receiving lower dosages. Patients receiving combination treatment of a neuroleptic with either lithium, an anticonvulsant, or a benzodiazepine received a mean neuroleptic dosage similar to that of patients treated with a neuroleptic alone. CONCLUSIONS: Although their use has been widely discouraged for mood disorders, neuroleptics have been the standard treatment for acute mania.


This article has been cited by other articles:


Home page
 Adv. Psychiatr. Treat.Home page
J. Cookson
Atypical antipsychotics in bipolar disorder: the treatment of mania
Advan. Psychiatr. Treat., September 1, 2008; 14(5): 330 - 338.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
G. M. Goodwin
Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from the British Association for Psychopharmacology
J Psychopharmacol, June 1, 2003; 17(2): 149 - 173.
[Abstract] [PDF]

Home page
 Br. J. PsychiatryHome page
S. F. B. McTAVISH, M. H. McPHERSON, C. J. HARMER, L. CLARK, T. SHARP, G. M. GOODWIN, and P. J. COWEN
Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness
The British Journal of Psychiatry, October 1, 2001; 179(4): 356 - 360.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
J. COOKSON
Use of antipsychotic drugs and lithium in mania
The British Journal of Psychiatry, June 1, 2001; 178 (41): s148 - s156.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Ment. HealthHome page
A. C Swann
Valproate for acute mania reduced neuroleptic administration and improved symptoms on mania and global function scales
Evid. Based Ment. Health, November 1, 2000; 3(4): 113 - 113.
[Full Text]


homecopy help contact us subscription past issues search current issue
Copyright © 1996 by Harvey Whitney Books Company.